Literature DB >> 23307491

Neurologic Complications and Considerations in HIV-Infected Persons.

Justin McArthur1, Bryan Smith.   

Abstract

Neurologic complications for HIV-infected persons retain significant prevalence despite an increasingly global use of antiretroviral therapies. Such complications are often ascribed to advanced immunosuppression; however, the most common neurologic problems for HIV-infected persons, distal sensory polyneuropathy and HIV-associated neurocognitive disorders, affect a significant proportion of patients who have successfully achieved immunologic restoration with normal or near-normal CD4 count levels and undetectable HIV RNA in the periphery. Understanding specific considerations for HIV-associated complications, including the epidemiology, risk factors, medication-adverse effects, and benefits of appropriate management, is vital for all providers caring for those with HIV. This review will describe such considerations, as well as providing a more detailed review of the most common neurologic complications of HIV infection, and will highlight some of the challenges involved with diagnosis, management, and long-term effects.

Entities:  

Year:  2013        PMID: 23307491      PMCID: PMC4313541          DOI: 10.1007/s11908-012-0312-2

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  46 in total

1.  A PEPTIDE UNCOUPLING CRMP-2 FROM THE PRESYNAPTIC Ca(2+) CHANNEL COMPLEX DEMONSTRATES EFFICACY IN ANIMAL MODELS OF MIGRAINE AND AIDS THERAPY-INDUCED NEUROPATHY.

Authors:  Matthew S Ripsch; Carrie J Ballard; May Khanna; Joyce H Hurley; Fletcher A White; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2012-03       Impact factor: 1.757

2.  Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals.

Authors:  M A Cole; J B Margolick; C Cox; X Li; O A Selnes; E M Martin; J T Becker; H A Aronow; B Cohen; N Sacktor; E N Miller
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

Review 3.  Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.

Authors:  M Yoshioka; W G Bradley; P Shapshak; I Nagano; R V Stewart; K Q Xin; A K Srivastava; S Nakamura
Journal:  Adv Neuroimmunol       Date:  1995

4.  Central nervous system viral invasion and inflammation during acute HIV infection.

Authors:  Victor Valcour; Thep Chalermchai; Napapon Sailasuta; Mary Marovich; Sukalaya Lerdlum; Duanghathai Suttichom; Nijasri C Suwanwela; Linda Jagodzinski; Nelson Michael; Serena Spudich; Frits van Griensven; Mark de Souza; Jerome Kim; Jintanat Ananworanich
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

5.  Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

Authors:  E J Wright; B Grund; K Robertson; B J Brew; M Roediger; M P Bain; F Drummond; M J Vjecha; J Hoy; C Miller; A C Penalva de Oliveira; W Pumpradit; J C Shlay; W El-Sadr; R W Price
Journal:  Neurology       Date:  2010-08-11       Impact factor: 9.910

Review 6.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

7.  Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

Authors:  Valerio Tozzi; Pietro Balestra; Rita Bellagamba; Angela Corpolongo; Maria Flora Salvatori; Ubaldo Visco-Comandini; Chrysoula Vlassi; Marinella Giulianelli; Simonetta Galgani; Andrea Antinori; Pasquale Narciso
Journal:  J Acquir Immune Defic Syndr       Date:  2007-06-01       Impact factor: 3.731

8.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.

Authors:  E A Childs; R H Lyles; O A Selnes; B Chen; E N Miller; B A Cohen; J T Becker; J Mellors; J C McArthur
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

9.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

10.  Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients.

Authors:  Douglas A Green; Eliezer Masliah; Harry V Vinters; Pouneh Beizai; David J Moore; Cristian L Achim
Journal:  AIDS       Date:  2005-03-04       Impact factor: 4.177

View more
  7 in total

1.  Plasma gelsolin protects HIV-1 gp120-induced neuronal injury via voltage-gated K+ channel Kv2.1.

Authors:  Han Liu; Jianuo Liu; Shangdong Liang; Huangui Xiong
Journal:  Mol Cell Neurosci       Date:  2013-11       Impact factor: 4.314

2.  The impact of human immune deficiency virus and hepatitis C coinfection on white matter microstructural integrity.

Authors:  J M Heaps-Woodruff; P W Wright; B M Ances; D Clifford; R H Paul
Journal:  J Neurovirol       Date:  2015-12-21       Impact factor: 2.643

3.  Enhancement of NMDA receptor-mediated excitatory postsynaptic currents by gp120-treated macrophages: implications for HIV-1-associated neuropathology.

Authors:  Jianming Yang; Dehui Hu; Jianxun Xia; Jianuo Liu; Gang Zhang; Howard E Gendelman; Nawal M Boukli; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-10       Impact factor: 4.147

4.  A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.

Authors:  Thomas D Marcotte; Reena Deutsch; Benedict Daniel Michael; Donald Franklin; Debra Rosario Cookson; Ajay R Bharti; Igor Grant; Scott L Letendre
Journal:  J Neuroimmune Pharmacol       Date:  2013-10-08       Impact factor: 4.147

5.  Anti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection.

Authors:  Jennifer H Campbell; Eva-Maria Ratai; Patrick Autissier; David J Nolan; Samantha Tse; Andrew D Miller; R Gilberto González; Marco Salemi; Tricia H Burdo; Kenneth C Williams
Journal:  PLoS Pathog       Date:  2014-12-11       Impact factor: 6.823

6.  CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders.

Authors:  Dionna W Williams; Desiree Byrd; Leah H Rubin; Kathryn Anastos; Susan Morgello; Joan W Berman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-10-09

7.  Astrocytic expression of HIV-1 viral protein R in the hippocampus causes chromatolysis, synaptic loss and memory impairment.

Authors:  Lilith Torres; Richard J Noel
Journal:  J Neuroinflammation       Date:  2014-03-22       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.